Study of VentureMed ’ s Flex catheter begins in Switzerland
Vascular-focused device developer VentureMed said yesterday that it has launched another study of its Flex dynamic scoring catheter, this one to measure how open patients’ blood vessels remain 12 months after treatment. The prospective, single arm, non-randomized study in Switzerland will enroll up to 150 patients whose superficial femoral and popliteal arteries were scored by the Flex system before drug-eluting balloon angioplasty. Flex creates long, parallel, linear micro-incisions in all plaque-lined arteries. Dr. Daniel Périard and Dr. Rolf Engelberger, both of the angiology department at HF...
Source: Mass Device - January 18, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: Blog News Well Research & Development Vascular internationalsymposiumonvasculartherapy venturemed Source Type: news

Asceneuron Appoints Peter Van Vlasselaer as Chairman
Serial biotech entrepreneur joins leading small molecule tau modulation company LAUSANNE, Switzerland and CAMBRIDGE, Ma., January 17, 2019 -- (Healthcare Sales & Marketing Network) -- Asceneuron, an emerging leader in the development of orally bioavail... Biopharmaceuticals, Neurology, Personnel Asceneuron, Progressive Supranuclear Palsy, tau pathology (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 17, 2019 Category: Pharmaceuticals Source Type: news

Insilico to present latest advances in AI for drug discovery at R & D Data Intelligence Leaders Forum
(InSilico Medicine, Inc.) Insilico presents its latest results in modern and next-generation AI for Drug Discovery at the R&D Data Intelligence Leaders Forum in Basel, Switzerland, 24 of January. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 17, 2019 Category: International Medicine & Public Health Source Type: news

German Village Evacuated Amid Avalanche Risk
BERLIN (AP) — Officials have ordered residents of a village in southern Germany to leave their homes immediately due to "acute" avalanche risk. Authorities said Wednesday that villagers of Raiten, near the Austrian border, should take important documents and medicines with them, and inform neighbors who may be unaware of the warning. Heavy snowfall over the past weeks has greatly heightened the risk of avalanches in parts of Germany, Austria and Switzerland. Dozens of people have died in avalanches and weather-related accidents. The German meteorological service DWD said Wednesday that the amount of snowfal...
Source: JEMS: Journal of Emergency Medical Services News - January 16, 2019 Category: Emergency Medicine Tags: International News Source Type: news

Therachon is Granted Orphan Drug Designation by US FDA for Apraglutide for the Treatment of Short Bowel Syndrome
Second Orphan Drug Designation for apraglutide, a next-generation, synthetic GLP-2 analog with a potentially best-in-class profile BASEL, Switzerland, Jan. 16, 2019 -- (Healthcare Sales & Marketing Network) -- Therachon AG ("Therachon"), a cl... Biopharmaceuticals, Gastroenterology, FDA Therachon, apraglutide, short bowel syndrome, achondroplasia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 16, 2019 Category: Pharmaceuticals Source Type: news

Breast cancer cells could be stopped from spreading if they are turned into FAT cells instead
Cancer cells can spread and grow by transitioning into stem-like cells. During transition, scientists in Switzerland have been able to coax them into becoming fat cells. (Source: the Mail online | Health)
Source: the Mail online | Health - January 15, 2019 Category: Consumer Health News Source Type: news

Breast cancer cells in mice tricked into turning into fat cells
(Cell Press) As cancer cells respond to cues in their microenvironment, they can enter a highly plastic state in which they are susceptible to transdifferentiation into a different type of cell. Researchers at the University of Basel in Switzerland exploited this critical phase, known as an epithelial-mesenchymal transition (EMT), to coax breast cancer cells in mice to turn into harmless fat cells. The proof-of-concept study appears Jan. 14, 2019, in the journal Cancer Cell. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 14, 2019 Category: Cancer & Oncology Source Type: news

Six Killed in Minibus Crash in Sweden
BERLIN (AP) — Switzerland says six of its citizens have been killed in a road crash in northern Sweden. The foreign ministry in Bern said Sunday that a Swiss consular official had been sent to the region to help the victims' families, but gave no further details on the deaths. It said one person was injured in the crash. Swedish media reported Saturday that a mining truck crashed into a minibus, killing six of the seven passengers in the bus. Swedish mining company Kaunis Iron said one of its trucks had crashed head-on with another vehicle in the Kiruna municipality near the border with Finland early Saturday. All co...
Source: JEMS: Journal of Emergency Medical Services News - January 13, 2019 Category: Emergency Medicine Tags: International Major Incidents News Mass Casualty Incidents Source Type: news

Predictive validity of the Static-99 and Static-99R in Switzerland - Gon çalves LC, Gerth J, Rossegger A, Noll T, Endrass J.
This study evaluated the validity of the Static-99 and Static-99R in assessing sexual recidivism in Switzerland, based on a sample of 142 male sex offenders. Both tools showed predictive validity, but the Static-99R had better discrimination (OR = 1.82, AU... (Source: SafetyLit)
Source: SafetyLit - January 11, 2019 Category: International Medicine & Public Health Tags: Jurisprudence, Laws, Legislation, Policies, Rules Source Type: news

Zimbabwe: Swiss Foreign Minister Pledges Support for HIV/Aids Programmes
[New Zimbabwe] SWITZERLAND'S Foreign Affairs Minister Ignazio Cassis has pledged his country's support for Zimbabwe fight against HIV and AIDS. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - January 11, 2019 Category: Infectious Diseases Source Type: news

Fire and EMS Crews Examine Suspicious Packages in Australian Cities
SYDNEY (AP) — Several foreign diplomatic missions were evacuated in the Australian cities of Melbourne and Canberra on Wednesday after they received packages containing suspicious substances. Police, fire crews and ambulances were seen at a number of foreign consulates in Melbourne, including those of India, Germany, Italy, Spain and South Korea. Officials at the U.S. and Swiss missions in the city said they had also received packages. The Vic Emergency website, the collective body of emergency agencies in Victoria state, of which Melbourne is the capital, noted at least 10 "hazardous material" incidents in...
Source: JEMS: Journal of Emergency Medical Services News - January 10, 2019 Category: Emergency Medicine Tags: International News Source Type: news

EMS and Fire Crews Examine Suspicious Packages in Australian Cities
SYDNEY (AP) — Several foreign diplomatic missions were evacuated in the Australian cities of Melbourne and Canberra on Wednesday after they received packages containing suspicious substances. Police, fire crews and ambulances were seen at a number of foreign consulates in Melbourne, including those of India, Germany, Italy, Spain and South Korea. Officials at the U.S. and Swiss missions in the city said they had also received packages. The Vic Emergency website, the collective body of emergency agencies in Victoria state, of which Melbourne is the capital, noted at least 10 "hazardous material" incidents in...
Source: JEMS: Journal of Emergency Medical Services News - January 10, 2019 Category: Emergency Medicine Authors: Trevor Marshallsea, Associated Press Tags: International Major Incidents News Source Type: news

Speeding up genetic diagnosis of Huntington's disease
(Swiss National Science Foundation (SNSF)) Elongated segments of DNA cause Huntington's disease and certain other disorders of the brain. Researchers funded by the SNSF have developed a method to determine the length of the mutated genes quickly and easily. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 10, 2019 Category: International Medicine & Public Health Source Type: news

Drug May Delay MS Disability for Some
A new Swiss study found that people who have secondary progressive MS who took the drug rituximab reported less disabling symptoms over a 10-year period than those who didn't. People taking the drug also had a slower progression of MS symptoms. (Source: WebMD Health)
Source: WebMD Health - January 9, 2019 Category: Consumer Health News Source Type: news

New hope for a diabetes cure: Cells in the pancreas could be 'manipulated' into producing insulin  
A study by the universities of Bergen, Norway, and Geneva, Switzerland, found that when beta cells - which make insulin - are wiped out in mice, surrounding cells step in and make the hormone. (Source: the Mail online | Health)
Source: the Mail online | Health - January 9, 2019 Category: Consumer Health News Source Type: news

Cannabinoid concentrations in confiscated cannabis samples and in whole blood and urine after smoking CBD-rich cannabis as a "tobacco substitute" - H ädener M, Gelmi TJ, Martin-Fabritius M, Weinmann W, Pfäffli M.
In Switzerland, only cannabis with a total Δ9-tetrahydrocannabinol (THC) content higher than 1% is controlled by the narcotics legislation. Cannabis products rich in cannabidiol (CBD) and low in THC can be legally sold as tobacco substitutes. I... (Source: SafetyLit)
Source: SafetyLit - January 8, 2019 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Swiss Researchers Struggle to Get Animal Experiments Approved
Scientists say that increasingly rigorous licensing procedures have complicated research efforts--and in some cases, stopped experiments completely. (Source: The Scientist)
Source: The Scientist - January 8, 2019 Category: Science Tags: News & Opinion Source Type: news

Surveillance Report
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 2019. This five-page report is based on data on zoonotic influenza for 2017 retrieved from Epidemic Intelligence on May 18, 2018. No human cases of avian influenza were reported in the European Union/European Economic Area. Sporadic cases were reported from Africa and Asia. Influenza viruses A(H1N1)v, A(H1N2)v, and A(H3N2)v of swine origin caused human cases in Switzerland and the United States. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - January 8, 2019 Category: International Medicine & Public Health Source Type: news

Surveillance Report: Annual Epidemiological Report for 2017; Zoonotic Influenza
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 2019. This five-page report is based on data on zoonotic influenza for 2017 retrieved from Epidemic Intelligence on May 18, 2018. No human cases of avian influenza were reported in the European Union/European Economic Area. Sporadic cases were reported from Africa and Asia. Influenza viruses A(H1N1)v, A(H1N2)v, and A(H3N2)v of swine origin caused human cases in Switzerland and the United States. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - January 8, 2019 Category: International Medicine & Public Health Source Type: news

Grand Strand Sandwich Company Recalls Lunch Box Sandwiches Italian Subs Lunch Box Sandwiches Ham & Swiss Croissants And Lunch Box Sandwiches Ham & Cheese Due To Possible < em > Listeria Monocytogenes < /em > Contamination
– Grand Strand Sandwich is recalling Lunch Box Italian Subs, Lunch Box Ham& Swiss Croissants and Lunch Box Ham& Cheese Frozen Wedges due to a potential contamination ofListeria Monocytogenes. (Source: Food and Drug Administration)
Source: Food and Drug Administration - January 8, 2019 Category: Food Science Source Type: news

New Study Finds Discrepancies in Cervical Cancer Screening Rates
A new Mayo Clinic study shows that the percentage of women who are screened for cervical cancer could be far lower than national data suggests. The researchers' findings were published in the Journal of Women’s Health and show that less than two thirds of women ages 30 to 65 were up-to-date with cervical cancer screenings in 2016. What’s telling is the percentage is even lower for women ages 21 to 29, with just over half current on screenings. Mayo Clinic Researchers said those figures are well below the 81% screening compliance rate that was self-reported in the 2015 National Health Int...
Source: MDDI - January 7, 2019 Category: Medical Devices Authors: MDDI Staff Tags: IVD Testing Source Type: news

Invitation to Roche's Full Year Results 2018 Presentation
Roche will publish its Full Year Results for 2018 prior to the opening of the Swiss Stock Exchange on Thursday, 31 January 2019. (Source: Roche Investor Update)
Source: Roche Investor Update - January 7, 2019 Category: Pharmaceuticals Source Type: news

Oculis Expands Portfolio with the In-Licensing of a Novel Phase II-stage Anti-TNF Alpha Antibody Fragment
LAUSANNE, Switzerland, January 4, 2019 -- (Healthcare Sales & Marketing Network) -- Oculis SA, a clinical-stage biopharmaceutical company developing next-generation topical ophthalmic treatments, has entered into an agreement to in license a novel topical... Biopharmaceuticals, Ophthalmology, Licensing Oculis , Novartis, Dry Eye Disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 4, 2019 Category: Pharmaceuticals Source Type: news

Oculis Raises CHF15.5 Million in an Extension of its Series B Financing Round - Total Raised CHF35.5 Million
New funds to expand portfolio and advance development of novel topical treatments for ophthalmic diseases LAUSANNE, Switzerland, January 4, 2019 -- (Healthcare Sales & Marketing Network) -- Oculis SA, a clinical-stage biopharmaceutical company developi... Biopharmaceuticals, Ophthalmology, Venture Capital Oculis , Diabetic Macular Edema (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 4, 2019 Category: Pharmaceuticals Source Type: news

Why So Many Women Travel to Denmark for Fertility Treatments
Holly Ryan knows the biological father of her children has two sisters, is a Coldplay fan, and doesn’t like eating chicken in pasta dishes. She knows his mother is a nurse and his father is a policeman, and that his aunt has green eyes and curly hair. She even has a photo of him as a child, and an audio recording of his voice. But Ryan, 41, doesn’t know his name and has never met him. More than six years ago, she decided she wanted to start a family. “Once you commit to trying to get pregnant, it becomes a kind of obsession,” says Ryan, the director of a talent agency for TV directors, producers and...
Source: TIME: Health - January 3, 2019 Category: Consumer Health News Authors: Naina Bajekal/Copenhagen Tags: Uncategorized Denmark Source Type: news

Altavant Sciences Appoints Lyn Baranowski Chief Operating Officer
BASEL, Switzerland and DURHAM, N.C., Jan. 2, 2019 -- (Healthcare Sales & Marketing Network) -- Altavant Sciences, a company in the Roivant family focused on clinical development of novel therapies for pulmonary arterial hypertension and other indications,... Biopharmaceuticals, Personnel Altavant Sciences, rodatristat ethyl (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 2, 2019 Category: Pharmaceuticals Source Type: news

Factors associated with involuntary hospitalisation for psychiatric patients in Switzerland: a retrospective study - Silva B, Golay P, Morandi S.
BACKGROUND: Despite the scarce evidence for patients' benefits of coercion and its well-documented negative effects, the use of compulsion is still very common around Europe, with important variations among different countries. These variations have been p... (Source: SafetyLit)
Source: SafetyLit - January 1, 2019 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Chemotherapy may cause breast cancer to SPREAD
The commonly prescribed chemo drugs paclitaxel and doxorubicin cause breast tumours to release proteins that then circulate in the blood until they reach the lungs, Swiss researchers found. (Source: the Mail online | Health)
Source: the Mail online | Health - December 31, 2018 Category: Consumer Health News Source Type: news

Injured Skier Airlifted from World Cup Course in Italy
BORMIO, Italy (AP) — Slovenian skier Klemen Kosi has been airlifted by helicopter to a local hospital after crashing in a World Cup downhill. Kosi lost control toward the end of the physically demanding Stelvio course and tumbled through two layers of safety netting before coming to a stop. His skis dislodged from his bindings and flew into the air as he hit the nets. Injury details were not immediately available. In more than 100 World Cup races, Kosi has only made the top 10 three times, with his best finish seventh in an Alpine combined event in Wengen, Switzerland, at the start of 2016. It's the second consecutiv...
Source: JEMS Patient Care - December 28, 2018 Category: Emergency Medicine Tags: International Rescue & Vehicle Extrication Patient Care Operations Source Type: news

Injured Skier Airlifted from World Cup Course in Italy
BORMIO, Italy (AP) — Slovenian skier Klemen Kosi has been airlifted by helicopter to a local hospital after crashing in a World Cup downhill. Kosi lost control toward the end of the physically demanding Stelvio course and tumbled through two layers of safety netting before coming to a stop. His skis dislodged from his bindings and flew into the air as he hit the nets. Injury details were not immediately available. In more than 100 World Cup races, Kosi has only made the top 10 three times, with his best finish seventh in an Alpine combined event in Wengen, Switzerland, at the start of 2016. It's the second consecutiv...
Source: JEMS Operations - December 28, 2018 Category: Emergency Medicine Tags: International Rescue & Vehicle Extrication Patient Care Operations Source Type: news

Delcath inks European licensing deal for Chemosat
Delcath Systems (OTC:DCTH) said this week that it inked a licensing deal with Germany-based medac for the commercialization of Chemosat in Europe. According to the terms of the seven-year agreement, Delcath’s European subsidiary will exclusively license its Chemosat system to Medac for sale in the EU, Norway, Liechtenstein, Switzerland and the UK. Medac is slated to pay $6.8 million to Delcath in a combination of upfront and milestone payments. Get the full story at our sister site, Drug Delivery Business News. The post Delcath inks European licensing deal for Chemosat appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - December 26, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Drug-Device Combinations Featured Oncology Wall Street Beat Delcath Systems Inc. Source Type: news

U.S Body Says Gene Therapy May Be More Cost Effective for Spinal Muscular Atrophy U.S Body Says Gene Therapy May Be More Cost Effective for Spinal Muscular Atrophy
Biogen Inc's Spinraza (nusinersen) treatment for spinal muscular atrophy and Swiss drugmaker Novartis AG's experimental gene therapy are both expensive, but the gene therapy could be more cost effective once more is known about its U.S. price and long-term success rates, a preliminary report from an independent U.S. nonprofit organization said on Thursday.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 24, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

U.S. body says gene therapy may be more cost effective for spinal muscular atrophy
Biogen Inc's Spinraza treatment for spinal muscular atrophy and Swiss drugmaker Novartis AG's experimental gene therapy are both expensive, but the gene therapy could be more cost effective once more is known about its U.S. price and long-term success rates, a preliminary report from an independent U.S. nonprofit organization said on Thursday. (Source: Reuters: Health)
Source: Reuters: Health - December 21, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

U.S body says gene therapy may be more cost effective for spinal muscular atrophy
Biogen Inc's Spinraza treatment for spinal muscular atrophy and Swiss drugmaker Novartis AG's experimental gene therapy are both expensive, but the gene therapy could be more cost effective once more is known about its U.S. price and long-term success rates, a preliminary report from an independent U.S. nonprofit organization said on Thursday. (Source: Reuters: Health)
Source: Reuters: Health - December 21, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Alcon & #039;s Acquisition Is a Real Tear-Jerker
Alcon's anticipated split from Novartis has yet to be completed but the eye care business already is looking for ways to build out its portfolio for when it becomes a standalone company. Alcon reported Wednesday that it has acquired Tear Film Innovations, a private company that makes the iLux device used to treat Meibomian Gland Dysfunction, a leading cause of dry eye. The news comes at the end of what has been a bumpy year for Alcon, which was acquired by Novartis in 2011 for $12.9 billion. In June Novartis reported plans to split from Alcon, which will create a new Switzerland-based company. Just a couple mon...
Source: MDDI - December 19, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Novartis, China's Gan & Lee push into insulin amid diabetes epidemic
Swiss drugmaker Novartis aims to become a big player in supplying insulin to swelling numbers of diabetics, signing a deal with China's Gan& Lee on versions of three blockbuster brands as the U.S. government is seeking to slash insulin costs. (Source: Reuters: Health)
Source: Reuters: Health - December 19, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Novartis links with China's Gan & Lee in global insulin push
Swiss drugmaker Novartis aims to become a big player in supplying insulin to diabetics, signing a deal with China's Gan& Lee covering versions of three blockbuster brands just as the U.S. government is seeking to slash insulin costs. (Source: Reuters: Health)
Source: Reuters: Health - December 19, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Anticancer vaccines gain new lease of life with personalisation techniques
Anticancer vaccines have gained a new lease of life with techniques to personalise them to individual patients. Cutting edge developments in this re-energised field were revealed at the ESMO Immuno-Oncology Congress in Geneva, Switzerland. The original anticancer vaccines, launched in the late 1990s, were based on shared tumour antigens and failed to induce a potent immune response. (Source: World Pharma News)
Source: World Pharma News - December 19, 2018 Category: Pharmaceuticals Tags: Featured Development Research and Development Source Type: news

Switzerland prepares to launch Iran payments channel
Swiss initiative has US approval and rivals EU plan to bypass sanctions (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - December 19, 2018 Category: Pharmaceuticals Source Type: news

Molecular Partners agrees cancer immunotherapy deal with Amgen
Swiss biotechnology company Molecular Partners said it could earn more than $500 million in payments after striking a deal with U.S. drug giant Amgen to work together in cancer immunotherapy. (Source: Reuters: Health)
Source: Reuters: Health - December 19, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Anticancer vaccines gain new lease of life with personalisation techniques
(European Society for Medical Oncology) Anticancer vaccines have gained a new lease of life with techniques to personalise them to individual patients. Cutting edge developments in this re-energised field were revealed at the ESMO Immuno-Oncology Congress in Geneva, Switzerland. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 19, 2018 Category: Cancer & Oncology Source Type: news

Amgen And Molecular Partners Announce Strategic Collaboration In Immuno-Oncology
Parties Will Jointly Develop MP0310, a Pre-clinical FAP x 4-1BB Multi-Specific DARPin® Molecule, in Combination with Amgen's Oncology Assets, Including BiTE® Molecules Molecular Partners Retains Rights to Develop MP0310 in Combination With its Pipeline Products THOUSAND OAKS, Calif. and ZURICH-SCHLIEREN, Switzerland, Dec. 18, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Molecular Partners AG (SIX: MOLN), a clinical-stage biotech company pioneering the use of DARPin® therapeutics, today announced a collaboration and license agreement for the clinical development and commercialization of MP0310 (FAP x...
Source: Amgen News Release - December 19, 2018 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Prosecutors investigate spinal implant
Swiss prosecutors have launched an investigation into a failed spinal implant approved by UK regulators. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - December 19, 2018 Category: Consumer Health News Source Type: news

Changes in injury incidences and causes in Swiss amateur soccer between the years 2004 and 2015 - Gebert A, Gerber M, P ühse U, Faude O, Stamm H, Lamprecht M.
BACKGROUND: Injury prevention in amateur soccer has been promoted in recent years, but only a few studies have addressed long-term changes in injury incidence in amateur soccer. However, better knowledge of changes with respect to injury incidences and cau... (Source: SafetyLit)
Source: SafetyLit - December 18, 2018 Category: International Medicine & Public Health Tags: Recreational and Sports Issues Source Type: news

Gender Gap Seen in Prehospital Urgency for MI, Cardiac Arrest
(MedPage Today) -- Swiss and U.S. studies show disparities persist (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - December 18, 2018 Category: Cardiology Source Type: news

Buruli ulcer: Promising new drug candidate against a forgotten disease
(Swiss Tropical and Public Health Institute) Buruli ulcer is a neglected tropical disease (NTD) resulting in debilitating skin lesions, disabilities and stigmatisation. The current antibiotic treatment is long and has severe adverse side effects. Researchers from the Swiss Tropical and Public Health Institute (Swiss TPH) together with colleagues from Singapore have discovered a highly effective compound against Buruli ulcer which has the potential to become a powerful alternative to the existing treatment options. Results were published today in the peer-reviewed journal Nature Communications. (Source: EurekAlert! - Infect...
Source: EurekAlert! - Infectious and Emerging Diseases - December 18, 2018 Category: Infectious Diseases Source Type: news

Don ’t be shy: a dose of narcissism is good for you | Oliver Burkeman
The unhealthy narcissist ’s secret fear is that if he’s not God, he’s nothing. The healthy narcissist knows the middle wayIn what undoubtedly qualifies as one of the sickest burns in modern politics, Denmark ’s finance minister, Kristian Jensen,observed last year, “There are two kinds of European nations: there are small nations and there are countries that have not yet realised they are small nations.” Jensen’s not-so-veiled swipe at Britain was more accurate than he knew. In arecent study, people from 35 nations were asked “What contribution do you think the country you are...
Source: Guardian Unlimited Science - December 14, 2018 Category: Science Authors: Oliver Burkeman Tags: Health & wellbeing Life and style Psychology Politics Source Type: news

Lilly partners with AC Immune for Alzheimer's treatment
U.S. drugmaker Eli Lilly& Co and AC Immune SA have agreed to jointly develop the Swiss biotech's potential treatment for Alzheimer's disease. (Source: Reuters: Health)
Source: Reuters: Health - December 12, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Women Often Wait to Call Help in a Heart Attack
Researchers in Switzerland found that women suffering a heart attack typically waited 37 minutes longer than men before calling an ambulance. (Source: WebMD Health)
Source: WebMD Health - December 11, 2018 Category: Consumer Health News Source Type: news

When Heart Attack Strikes, Women Often Hesitate to Call for Help
TUESDAY, Dec. 11, 2018 -- Women often delay calling for emergency help when heart attack symptoms start, a new study finds. Researchers in Switzerland found that women suffering a heart attack typically waited 37 minutes longer than men before... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 11, 2018 Category: General Medicine Source Type: news